Pravastatin improves low-density lipoprotein oxidation in renal transplantation

By Cofan F.   Zambon D.   Laguna J.C.   Casals E.   Ros E.   Cofan M.   Campistol J.M.   Oppenheimer F.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 389-391

Elsevier

Access to resources Recommend Favorite

Oxidation of Low-Density Lipoprotein in Atherosclerosis from Basic Biochemistry to Clinical Studies

By  

Current Molecular Medicine, Vol. 2, Iss. 6, 2002-09 ,pp. : 579-592

Bentham Science Publishers

Access to resources Recommend Favorite

Lovastatin Therapy for X-Linked Adrenoleukodystrophy: Clinical and Biochemical Observations on 12 Patients

By Shashidhar Pai G.   Khan M.   Barbosa E.   Key L.L.   Craver J.R.   Curé J.K.   Betros R.   Singh I.  

Molecular Genetics and Metabolism, Vol. 69, Iss. 4, 2000-04 ,pp. : 312-322

Academic Press

Access to resources Recommend Favorite

Evaluation of the therapeutic potential of PPAR agonists for X-linked adrenoleukodystrophy

By Rampler H.   Weinhofer I.   Netik A.   Forss-Petter S.   Brown P.J.   Oplinger J.A.   Bugaut M.   Berger J.  

Molecular Genetics and Metabolism, Vol. 80, Iss. 4, 2003-12 ,pp. : 398-407

Elsevier

Access to resources Recommend Favorite

Low-density lipoprotein composition and oxidation are not influenced by calcineurin inhibitors in renal transplant patients

By Morena M.   Vela C.   Garrigue V.   Catanzano J.   Descomps B.   Cristol J.P.   Mourad G.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2785-2786

Elsevier

Access to resources Recommend Favorite